CE Information

This activity is jointly provided by Partners for Advancing Clinical Education and Catamount Medical Education.

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

This activity can take up to 30 minutes to complete.

Date
Released On: January 16, 2026
Expires On: January 16, 2027

Target Audience
This activity is intended for psychiatry physicians, physician associates (PAs), and nurse practitioners (NPs).

Learning Objectives
Upon completion of this activity, participants should be able to:

• Describe unmet needs in the treatment of patients with schizophrenia
• Review the latest clinical evidence for novel schizophrenia therapies

Faculty
Peter J. Weiden, MD
Clinical Professor of Psychiatry, Department of Psychiatry
SUNY Stony Brook College of Medicine
Principal Investigator, CNS Clinical Trials
Richmond Behavioral Associates
Staten Island, NY

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Catamount Medical Education. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

Credit Designation
Physician Continuing Education
Partners designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Designated for 0.5 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

PA Continuing Medical Education
Partners has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. Approval is valid until September 15, 2026. PAs should only claim credit commensurate with the extent of their participation.

All other health care professionals completing this course will be issued a statement of participation.

Disclosures
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, reselling, or distributing health care products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

Faculty Disclosures

Peter J. Weiden, MD
Advisor Fees: Alkermes; Anavex Life Sciences; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Delpor, Inc.; MapLight Therapeutics; Neurocrine Biosciences; Teva Pharmaceutical Industries Ltd.; Vanda Pharmaceuticals
Consultant Fees: Alkermes; Anavex Life Sciences; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; MapLight Therapeutics; Neurocrine Biosciences; Teva Pharmaceutical Industries Ltd.; Vanda Pharmaceuticals
Speaker Fees: Alkermes; Anavex Life Sciences; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; MapLight Therapeutics; Neurocrine Biosciences; Teva Pharmaceutical Industries Ltd.; Vanda Pharmaceuticals
Researcher for: Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb; Intra-Cellular Therapies
Principal Investigator: Neurocrine Biosciences; Vanda Pharmaceuticals; Intra-Cellular Therapies
Stock Options: Delpor, Inc.

Activity Staff Disclosures
The planners, reviewers, editors, staff, continuing education (CE) committee, or other members at Catamount Medical Education who control content have disclosed no relevant financial relationships.

How to Participate in This Activity and Obtain CE Credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must:

1. Read the CE information
2. Complete the pretest
3. Study the educational content
4. Complete the posttest and the evaluation form

A score of 75% correct must be achieved on the posttest to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the posttest. You may retake the posttest until successful.

Upon completion of the posttest and evaluation, your certificate will be emailed to you.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Contact Information
For questions about this activity, please contact Catamount Medical Education at info@catmeded.com. For additional information about the accreditation of this activity, please visit https://partnersed.com.